ICC lands GSK cold sore retail brand

Share this article:
Interpublic Group's ICC will handle professional advertising for GlaxoSmithKline over-the-counter cold sore cream Abreva after winning the account this month. The AOR account represents the first business to come from GSK Consumer Healthcare since ICC earned a spot on the unit's agency roster this year.

Abreva is the only OTC cold sore remedy approved by the FDA to shorten healing time and the duration of symptoms, according to the manufacturer.

ICC will market the retail brand to pharmacists and, possibly, other healthcare professionals such as NPs and PAs. There was no incumbent AOR for expert marketing, a source at the agency told MM&M. Grey handles general advertising and promotion, and Ryan oversees in-store promotion.

ICC has experience marketing cosmetic products. Lowe sibling Deutsch managed DTC work on Novartis toenail fungus drug Lamisil, which became synonymous with animated character Digger the Dermatophyte portrayed in television ads, and ICC worked the professional side of the account. Lamisil went off-patent in 2007.

The new Abreva campaign will include journal advertising, advertorial development and website updates.

ICC said it is one of only two or three agencies chosen for GSK Consumer Healthcare's agency roster.
Share this article:

Email Newsletters

More in News

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.

Gilead, Merck HCV marketing battle may be on horizon

Gilead, Merck HCV marketing battle may be on ...

Disclosed in its earnings report yesterday, Gilead may have a card up its sleeve to counter Merck's experimental hep. C combo regimen.

Sales of Biogen MS pill pick up overseas

Sales of Biogen MS pill pick up overseas

Biogen Idec is seeing strong sales for blockbuster MS drug Tecfidera, especially overseas where it's beginning to catch fire this summer.